Pappas Capital LLC

10/23/2006 | Press release | Archived content

BrainCells and Organon to collaborate in discovery and developmen...

News | 10. 23. 2006

BrainCells

BrainCells Inc. (BCI) and Organon, the human health care business unit of Akzo Nobel (Nasdaq: AKZOY), today announced they will collaborate in the discovery and development of drugs for the treatment of central nervous system (CNS) disorders.

Pappas Capital LLC published this content on October 23, 2006, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 22, 2026 at 10:12 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]